Skip to main content

Search

19 result(s) for 'author#"H. G. M. Leufkens"' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Tenofovir disoproxil fumarate (TDF) is a nucleotide analogue recommended in international HIV treatment guidelines. Purpose of this study was to estimate the long term effects of TDF on renal profile in a coho...

    Authors: Edmund T. Nartey, Raymond A. Tetteh, Barbara A. Yankey, Aukje K. Mantel-Teeuwisse, Hubert G. M. Leufkens, Alexander N. O. Dodoo and Margaret Lartey

    Citation: BMC Research Notes 2019 12:445

    Content type: Research note

    Published on:

  2. Breast cancer is the most common type of cancer among women worldwide. In low and middle-income countries (LMICs), appropriate selection of medicines on national essential medicines lists (NEMLs) is a first st...

    Authors: Y. T. Bazargani, A. de Boer, J. H. M. Schellens, H. G. M. Leufkens and Aukje K. Mantel-Teeuwisse

    Citation: BMC Cancer 2015 15:591

    Content type: Research article

    Published on:

  3. To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and outcomes by patients’ human immunodeficiency virus (HI...

    Authors: Evans L Sagwa, Aukje K Mantel-Teeuwisse and Nunurai C Ruswa

    Citation: Journal of Pharmaceutical Policy and Practice 2014 7:14

    Content type: Research

    Published on:

  5. Laboratory testing in clinical practice is never a random process. In this study we evaluated testing bias for neutrophil counts in clinical practice by using results from requested and non-requested hematolog...

    Authors: Karin J Velthove, Hubert GM Leufkens, Patrick C Souverein, René C Schweizer and Wouter W van Solinge

    Citation: Emerging Themes in Epidemiology 2010 7:2

    Content type: Methodology

    Published on:

  6. National pharmacovigilance centres (national centres) are gradually gaining visibility as part of the healthcare delivery system in Africa. As does happen in high-income countries, it is assumed that national ...

    Authors: H. Hilda Ampadu, Jarno Hoekman, Daniel Arhinful, Marilyn Amoama-Dapaah, Hubert G. M. Leufkens and Alex N. O. Dodoo

    Citation: Globalization and Health 2018 14:109

    Content type: Research

    Published on:

  7. Continuous provision of appropriate medicines of assured quality, in adequate quantities, and at reasonable prices is a concern for all national governments. A national medicines policy (NMP) developed in a co...

    Authors: Joëlle M Hoebert, Liset van Dijk, Aukje K Mantel-Teeuwisse, Hubert GM Leufkens and Richard O Laing

    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:5

    Content type: Review

    Published on:

  8. Access to quality-assured medical products improves health and save lives. However, one third of the world’s population lacks timely access to quality-assured medicines while estimates indicate that at least 1...

    Authors: Lukas Roth, Daniel Bempong, Joseph B. Babigumira, Shabir Banoo, Emer Cooke, David Jeffreys, Lombe Kasonde, Hubert G. M. Leufkens, John C. W. Lim, Murray Lumpkin, Gugu Mahlangu, Rosanna W. Peeling, Helen Rees, Margareth Ndomondo-Sigonda, Andy Stergachis, Mike Ward…

    Citation: Globalization and Health 2018 14:102

    Content type: Review

    Published on:

  9. Regulators and payers have to strike a balance between the needs of the patient and the optimal allocation of resources. Drugs indicated for rare diseases (orphan medicines) are a special group in this context...

    Authors: Pieter Stolk, Harald E Heemstra, Hubert GM Leufkens, Brigitte Bloechl-Daum and Eibert R Heerdink

    Citation: Orphanet Journal of Rare Diseases 2009 4:27

    Content type: Research

    Published on:

  10. A rural pharmacy initiative (RPI) designed to increase access to medicines in rural Kyrgyzstan created a network of 12 pharmacies using a revolving drug fund mechanism in 12 villages where no pharmacies previo...

    Authors: Brenda Waning, Jason Maddix, Yorghos Tripodis, Richard Laing, Hubert GM Leufkens and Manjusha Gokhale

    Citation: International Journal for Equity in Health 2009 8:43

    Content type: Research

    Published on:

  11. There is limited information on patterns of treatment change among new initiators of highly active antiretroviral therapy (HAART) in the regions most affected by HIV/AIDS. This makes it difficult to identify t...

    Authors: Daniel N. A. Ankrah, Margaret Lartey, Aukje K. Mantel-Teeuwisse and Hubert G. M. Leufkens

    Citation: BMC Infectious Diseases 2017 17:664

    Content type: Research article

    Published on:

  12. Databases are frequently used for pharmacoepidemiological research. However, most of these databases consist either of prescribing, dispensing or administrative data and therefore lack insight in the interacti...

    Authors: Stefan R Florentinus, Patrick C Souverein, Fabiënne AMG Griens, Peter P Groenewegen, Hubert GM Leufkens and Eibert R Heerdink

    Citation: BMC Medical Informatics and Decision Making 2006 6:18

    Content type: Research article

    Published on:

  13. The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential m...

    Authors: Y. T. Bazargani, M. Ugurlu, A. de Boer, H. G. M. Leufkens and A. K. Mantel-Teeuwisse

    Citation: BMC Cardiovascular Disorders 2018 18:126

    Content type: Research article

    Published on:

  14. In the last 20–30 years, many international studies have found substantial differences in the use of (older) psychotropic medication between European countries. The majority mentioned an important role for att...

    Authors: J. M. Hoebert, A. K. Mantel-Teeuwisse, H. G. M. Leufkens and L. van Dijk

    Citation: BMC Health Services Research 2017 17:702

    Content type: Research article

    Published on:

  15. We studied to what extent the level of scientific knowledge on exceptionally rare metabolic inherited diseases and their potential orphan medicinal products is associated with sponsors deciding to apply for an...

    Authors: Michelle Putzeist, Aukje K Mantel-Teeuwisse, Christine C Gispen-de Wied, Arno W Hoes, Hubert GM Leufkens and Remco LA de Vrueh

    Citation: Orphanet Journal of Rare Diseases 2013 8:179

    Content type: Research

    Published on:

  16. In order to accurately distinguish gaps of varying length in drug treatment for chronic conditions from discontinuation without resuming therapy, short-term observation does not suffice. Thus, the use of inhal...

    Authors: Tanja T Menckeberg, Svetlana V Belitser, Marcel L Bouvy, Madelon Bracke, Jan-Willem J Lammers, Jan AM Raaijmakers and Hubert GM Leufkens

    Citation: BMC Health Services Research 2007 7:106

    Content type: Research article

    Published on:

  17. The assessment of the benefit-risk of medicines needs careful consideration concerning their patterns of utilization. Systems for the monitoring of medicines consumption have been established in many European ...

    Authors: Mònica Sabaté, Juan Fernando Pacheco, Elena Ballarín, Pili Ferrer, Hans Petri, Joerg Hasford, Marieke Wilma Schoonen, Marietta Rottenkolber, Joan Fortuny, Joan-Ramon Laporte and Luisa Ibáñez

    Citation: BMC Research Notes 2014 7:143

    Content type: Short Report

    Published on:

  18. Medical specialists are often seen as the first prescribers of new drugs. However, the extent to which specialists influence new drug prescribing in primary care is largely unknown.

    Authors: Stefan R Florentinus, Eibert R Heerdink, Liset van Dijk, AMG Fabiënne Griens, Peter P Groenewegen and Hubert GM Leufkens

    Citation: BMC Health Services Research 2009 9:6

    Content type: Research article

    Published on:

  19. There is strong evidence that post-exposure prophylaxis (PEP) with antiretroviral drugs in the timely management of occupational exposures sustained by healthcare workers decreases the risk of HIV infection an...

    Authors: Raymond A. Tetteh, Edmund T. Nartey, Margaret Lartey, Aukje K. Mantel-Teeuwisse, Hubert G. M. Leufkens, Priscilla A. Nortey and Alexander N. O. Dodoo

    Citation: BMC Public Health 2015 15:573

    Content type: Research article

    Published on: